Antihypertensive AgentsHypertensionBlood PressureHydrochlorothiazideAtenololAmlodipineDiureticsAngiotensin-Converting Enzyme InhibitorsHydralazineDoxazosinChlorthalidoneEnalaprilCalcium Channel BlockersBlood Pressure Monitoring, AmbulatoryMethyldopaRats, Inbred SHRHypertrophy, Left VentricularLisinoprilIndapamideSodium Chloride Symporter InhibitorsCilazaprilLosartanTrichlormethiazideBlood Pressure DeterminationCeliprololAngiotensin II Type 1 Receptor BlockersTetrazolesAdrenergic beta-AntagonistsSystoleRats, Inbred WKYCaptoprilAlbuminuriaPerindoprilDiabetic NephropathiesRisk FactorsTreatment OutcomeFollow-Up StudiesDrug Therapy, CombinationDouble-Blind MethodHypertension, RenalDiastoleCardiovascular DiseasesProspective StudiesBenzimidazolesBiphenyl CompoundsRamiprilNifedipineTime FactorsHeart RateAngiotensin Receptor AntagonistsPatient ComplianceMetoprololDiabetes Mellitus, Type 2AcrylatesCerebrovascular DisordersEchocardiographyRenin-Angiotensin SystemKidney Failure, ChronicValineCohort StudiesAge FactorsProteinuriaGlomerular Filtration RateStrokeDiabetic AngiopathiesDiabetes MellitusKidneyHemodynamicsDiabetes Mellitus, Type 1Diabetes ComplicationsCross-Sectional StudiesIncidenceVascular ResistanceRisk AssessmentPrevalenceThiazidesDose-Response Relationship, DrugRandomized Controlled Trials as TopicAnalysis of VarianceKidney DiseasesProportional Hazards ModelsSex FactorsCreatinineSingle-Blind MethodBody WeightDihydropyridinesMultivariate AnalysisPractice Guidelines as TopicLongitudinal StudiesUnited StatesBenzothiadiazinesBendroflumethiazideRetrospective StudiesPredictive Value of TestsLabetalolAgingRegression AnalysisReninBody Mass IndexMinoxidil